T1 Tissue Mapping as a Non Invasive Biomarker for Quantification of Chronic Thyroid Related Microscopic Myocardial Fibrosis.

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07247981

Enrollment

Registered

2025-11-25

Start date

2026-01-01

Completion date

2027-01-31

Last updated

2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Thyroid Disease

Brief summary

CMR T1 tissue mapping helps in detection and quantification of the microscopic myocardial fibrosis and is more accurate and non invasive maneuver.

Detailed description

Chronic thyroid diseased patients either hypo or hyperthyroidism may develop arrhythmias or even atrial fibrillation which is worrisome. And since early detection provides the early management, T1 tissue mapping of the heart provides accurate quantification of the myocardial fibrosis throughout the imaged organ.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* patients with chronic thyroid disease.

Exclusion criteria

* patients with other chronic illnesses ( diabetes, hypertension, .. etc). * patients received neck radiation therapy.

Design outcomes

Primary

Measure	Time frame	Description
Myocardial fibrosis	1 year	Detection and quantification of myocardial fibrosis.

Contacts

Primary ContactLina M Farid, MSc

Lina.m.farid@gmail.com01063455559

Backup ContactMoustafa A Sayyed, MD

Most.rad@aun.edu.eg01092300511

Outcome results